Tago, Christine .
HRN: 10-08-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2024
CEFUROXIME 500MG (TAB)
03/03/2024
03/10/2024
PO
500mg
BID
S/p NSVD With RMLE, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes